Note: Descriptions are shown in the official language in which they were submitted.
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
1
METHOD AND APPARATUS FOR DETECTING ARTIFACT SIGNALS IN
THE ELECTROCARDIOGRAM OF A PATIENT CAUSED BY CPR
AND/OR PATIENT MOTION USING PATIENT IMPEDANCE
Reference To Pending Prior Patent Application
This patent application claims benefit of pending
prior U.S. Provisional Patent Application Serial No.
60/592,993, filed 07/30/04 by Kyle R. Bowers for
METHOD AND APPARATUS FOR CPR AND ARTIFACT DETECTION
USING PATIENT IMPEDANCE (Attorney Docket No. ACCESS-4
PROV), which patent application is hereby incorporated
herein by reference.
Field Of The Invention
This invention relates to the measurement and
analysis of impedance signal variations in a patient.
More particularly, the present invention relates to a
method and apparatus for detecting artifact signals in
the electrocardiogram of a patient caused by CPR
and/or patient motion.
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
2
Background Of The Invention
An electrocardiogram (ECG) represents the
electrical activity of a patient's heart (see Fig. 2).
In general, cardiac monitoring and resuscitation
devices use the ECG waveform to determine the
condition of a patient's heart. Using sophisticated
algorithms, these devices analyze the heart's rhythm
to determine if the patient requires therapy. More
particularly, automatic external defibrillators (AEDs)
use these algorithms to determine if a patient's
rhythm is shockable, such as in the case of
ventricular fibrillation (see Fig. 3) or high-rate
ventricular tachycardia. AEDs also use these
algorithms to determine if a patient's rhythm is non-
shockable, such as where the ECG waveform contains QRS
complexes (i.e., where a series of deflections in an
electrocardiogram represents electrical activity
generated by ventricular depolarization prior to
contraction of the ventricles) or where the patient is
experiencing fine VF (below the shockable threshold)
(see Fig. 4) or asystole (see Fig. 5).
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
3
One common problem with analyzing a patient's
rhythm is the introduction of an artifact signal into
the ECG. It is difficult for cardiac devices and
monitoring devices to distinguish common artifact
signals from the underlying rhythm in the ECG signal.
An artifact signal can be introduced by CPR or by
motion of the patient during respiration or transport.
Such CPR artifact signals originate at the patient's
electrode-skin interface when the rescuer compresses
the patient's chest. If the device analyzing the
patient's rhythms has large electrode pads, such as an
AED, the rescuer may touch the pad when performing
chest compressions, thereby further aggravating the
problem of misleading artifacts.
One specific area of concern is with low cost
AEDs and monitoring devices. These devices must
analyze the patient's rhythm without some explicit
indication of the events causing the artifact signals
described above. In addition, these low cost devices
may lack the sophisticated electronics, sensors and/or
other resources which may be used to detect these
artifact signals.
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
4
In some instances, e.g., where CPR is performed
correctly, the artifact signal is generally sinusoidal
in appearance (Fig. 6A). However, if CPR is performed
by a layperson or performed during transport, the
artifact signal superimposed over a patient's
underlying non-shockable ECG rhythm may appear
shockable to the analyzing device. In some specific
cases, the resulting rhythm may begin to look like
ventricular fibrillation (Fig. 6B). The analyzing
device may misinterpret the rhythm as shockable and
prompt the rescuer to "Stand Clear" and stop
performing CPR. Then, the device analyzes the ECG
without the artifact signal, determines that the
rhythm is non-shockable, and the result is that the
rescuer is delayed in performing the necessary CPR
therapy. As is well known in the art, delays in
performing CPR on a cardiac arrest victim may
compromise the outcome of a successful resuscitation.
In cases where significant patient motion creates
an artifact signal, the super-imposed ECG rhythm may
also appear shockable. As is well known to those
skilled in the art, certain motion environments, such
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
as those of fixed-wing aircraft or helicopters, can
introduce a vibration at a resonant or harmonic
frequency which is related to the fundamental
frequency of the source (i.e., the aircraft engine),
and this can sometimes cause the monitoring equipment
to falsely report a shockable event.
Thus, there is a need for a new and low cost
approach for detecting the artifact signals introduced
by CPR and/or patient motion, whereby to improve
determinations of shockable conditions by monitoring
devices.
Summary Of The Invention
It has now been recognized that the transthoracic
impedance of the patient varies during CPR (see Fig.
7) and significant patient motion, and this phenomena
can be used to identify the presence of CPR and/or
motion artifacts in an ECG signal. More specifically,
by measuring variations in a transthoracic impedance
signal, it is possible to tell when a patient is
undergoing CPR and/or in heavy motion, and thus when
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
6
there may be CPR and/or heavy motion artifacts in an
ECG signal.
Since the transthoracic impedance signal and the
ECG signal do not correlate during CPR or heavy
motion, these signals must be considered
independently.
While the CPR-induced, and/or motion-induced,
changes in the transthoracic impedance signal and the
ECG signal generally time-correlate to one another,
they do not share a simple transformation function, so
it is generally simplest to consider the transthoracic
impedance signal and the ECG signal separately from
one another.
Therefore, the present invention provides a
method and apparatus for detecting CPR and/or motion
artifacts in the ECG signal of a patient by analyzing
variations in a measured electrical signal that
reflect changes in the patient's transthoracic
impedance. By monitoring the impedance variations
independently from ECG signal, this information may be
used as an indicator of the underlying ECG rhythm
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
7
classification, i.e. shockable or non-shockable
rhythm, or to interrupt the ECG analysis altogether.
In accordance with one preferred embodiment of
the present invention, the apparatus contains a
microprocessor and circuitry configured to measure the
patient's impedance, digitize the signal and store the
digitized data in memory for analysis. The apparatus
may also apply filtering techniques before and/or
after storing the impedance signal data.
The characterization of the patient's impedance
is generally achieved from an analysis of: (i) the
baseline of the impedance signal data, (ii) amplitude
variance of the impedance signal data, (iii) timing of
the impedance signal data, and/or (iv) pattern
recognition of the impedance signal data. In one
embodiment of the present invention, a predetermined
threshold may be applied to the amplitude variance.
The present invention may also conditionally (or non-
conditionally) use a combination or subset of the
above-identified parameters. The above-identified
parameters may also be weighted differently with
respect to one another. Still other characterization
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
8
techniques of the sort known in the art may be used
for the analysis of the patient's impedance.
In analyzing the baseline of the impedance signal
data, non-variance periods, signal averaging, or other
techniques known in the art may be used for the
analysis of the patient's impedance.
In analyzing the amplitude or timing of the
impedance signal data, trough-to-peak, peak-to-trough,
baseline-to-peak, baseline-to-trough, peak-to-peak,
trough-to-trough, rising slope, falling slope, Fast
Fourier Transforms or other techniques known in the
art may be used to detect the presence of CPR and/or
motion artifacts in the ECG signal.
In one preferred embodiment the present
invention, predetermined thresholds are applied to the
amplitude of the impedance signal data to detect the
presence of CPR and/or motion artifacts in the ECG
signal. These thresholds may be applied in different
operating modes of the apparatus, e.g., "analyze
rhythm", "shock advised", "press to shock", "check
patient", "CPR pause", etc. A sophisticated analysis
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
9
may be used to determine when the impedance variations
have exceeded such predetermined thresholds.
The present invention may be implemented in a
defibrillator that is configured to monitor the ECG
signal for the presence of the CPR and/or motion
artifacts in the ECG signal and, upon the detection of
such CPR and/or motion artifacts in the ECG signal, it
interrupts the analysis of the patient's ECG rhythm.
In still another embodiment of the present
invention, the characterization of the patient's
impedance signal data is used by the apparatus to
advise defibrillation therapy.
In yet another embodiment of the present
invention, the characterization of the patient's
impedance signal data is used by the apparatus to
identify a non-shockable rhythm and to indicate to the
user that defibrillation therapy is not advised.
In another embodiment of the present invention,
the characterization of the patient's impedance signal
data may be used by the apparatus to indicate a
shockable ECG rhythm, in which case defibrillation
therapy is advised, and CPR is not advised. In this
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
situation, bystanders are advised to not touch the
patient and stay clear of the patient.
And in another embodiment of the present
invention, the characterization of the patient's
impedance signal data is used by the apparatus to
advise the user to apply CPR or intravenous medicinal
therapy.
In one form of the invention, there is provided a
method for detecting artifact signals in the
electrocardiogram of a patient caused by CPR and/or
patient motion, the method comprising:
acquiring impedance signal data from the patient;
and
analyzing variations in the acquired impedance
signal data for characteristics indicative of artifact
signals caused by CPR and/or patient motion.
In another form of the invention, there is
provided an apparatus for detecting artifact signals
in an electrocardiogram of a patient caused by CPR
and/or patient motion, the apparatus comprising:
a signal circuit for passing an impedance-sensing
signal through a patient;
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
11
an impedance measuring circuit connected to the
signal circuit for measuring the impedance-sensing
signal;
a conversion circuit for digitizing the
impedance-sensing signal; and
a microprocessor for analyzing the digitized
signal data for characteristics indicative of CPR
and/or patient motion.
In another form of the invention, there is
provided a method for determining if a patient is
undergoing CPR and/or motion, the method comprising:
passing an impedance-sensing signal through the
chest of the patient; and
analyzing variations in the impedance-sensing
signal to determine when the patient is undergoing CPR
and/or motion.
In another form of the invention, there is
provided a method for treating a patient, the method
comprising:
measuring the electrocardiogram of the patient
and measuring variations in the transthoracic
impedance of the patient;
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
12
determining when the patient is undergoing CPR
and/or motion from variations in the transthoracic
impedance;
applying conventional defibrillation therapy to
the patient only if variations in the transthoracic
impedance indicate that the patient is not undergoing
CPR and/or motion.
In another form of the invention, there is
provided a method for treating a patient, the method
comprising:
measuring the electrocardiogram of the patient
and measuring variations in the transthoracic
impedance of the patient;
determining when the patient is receiving CPR
from a rescuer, by analyzing variations in the
transthoracic impedance;
allowing the rescuer to perform CPR therapy for a
predetermined period of time;
stopping the rescuer from performing CPR after
the predetermined period of time;
applying conventional defibrillation therapy to
the patient only if variations in the transthoracic
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
13
impedance indicate that the patient is not undergoing
CPR and/or motion.
Brief Description Of The Drawings
These and other objects and features of the
present invention will be more fully disclosed or
rendered obvious by the following detailed description
of the preferred embodiments of the invention, which
is to be considered together with the accompanying
drawings wherein like numbers refer to like parts and
further wherein:
Fig. 1 is a flow diagram of an example of a
therapy decision chart for a Sudden Cardiac Arrest
(SCA) over a timeline of 10 minutes - the
corresponding patient rhythms are shown in Figs. 2, 3,
4 and 5;
Fig. 2 is an exemplary ECG strip for a patient
with a normal sinus rhythm - the non-shockable rhythm
classification (N) is shown for each segment;
Fig. 3 is an exemplary ECG strip for a patient
experiencing a Ventricular Fibrillation (VF) rhythm -
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
14
the shockable rhythm classification (S) is shown for
each segment;
Fig. 4 is an exemplary ECG strip for a patient
experiencing a fine Ventricular Fibrillation rhythm -
the shockable rhythm classification (S) is shown for
each segment;
Fig. 5 is an exemplary ECG strip for-a patient in
asystole - the non-shockable rhythm classification (N)
is shown for each segment;
Figs. 6A and 6B are exemplary ECG strips where a
patient is in asystole and a rescuer is performing CPR
- the CPR rhythm is superimposed over the asystole
rhythm;
Fig. 7 illustrates the transthoracic impedance
signal corresponding to the ECG strip in Fig. 6A;
Fig. 8 illustrates a defibrillator and electrodes
attached to the patient;
Fig. 9 is a block diagram of a defibrillator
formed in accordance with the present invention;
Fig. 10 is a block diagram of an impedance
sensing circuit formed in accordance with the present
invention; and
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
Fig. 11 is a diagram of an impedance signal over
time; and
Fig. 12 is a diagram showing exemplary impedance
threshold values for each AED mode of operation.
Detailed Description Of The Preferred Embodiments
A device constructed in accordance with the
present invention is configured to determine the
presence of CPR or/motion artifacts in the patient's
ECG by analyzing variations in a patient's
transthoracic impedance. It should be appreciated
that this device may be a patient monitoring device or
a therapeutic device. By way of example, the device
may be an AED such as the one shown in Fig. 8. The
patient is connected to the device via a pair of
electrodes attached directly to the skin of the
patient's chest.
The defibrillator uses the electrodes to provide
a defibrillation shock to the heart of the patient,
where the defibrillation shock is a pulsed electrical
current, which passes through the patient's chest. In
addition, the defibrillator uses the electrodes to
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
16
sense ECG signals from the patient so as to determine
the condition of the patient's heart and hence
identify a shockable or non-shockable condition.
In accordance with the present invention, the
electrodes may be further used in conjunction with
impedance sensing circuitry in the defibrillator to
detect changes in the patient's transthoracic
impedance and hence determine if CPR and/or motion
artifacts are present in the patient's ECG signal such-
as the ECG signal may be unreliable for determining a
shockable or non-shockable condition.
Several techniques may be used for measuring
patient transthoracic impedance. A block diagram of
the form of impedance sensing circuit is shown in Fig.
10.
More particularly, the transthoracic impedance of
a human body can be modeled as a resistor in series
with a capacitor. The impedance circuit preferably
uses a 32KHz square wave voltage source, which is
delivered to the patient via an isolation transformer
and a filter circuit, which converts the input signal
into a constant current sine wave. The constant
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
17
current input signal applied to the patient produces
an output signal having an output voltage in
proportion to the patient's impedance. The impedance
circuit synchronously demodulates and then averages
the first 180 degrees of the output signal, which
removes the capacitive reactance from the patient's
impedance. The resulting DC voltage is directly
proportional to the resistance of the patient's body.
A block diagram of the defibrillator components
is shown in Fig. 9. The defibrillator contains a data
acquisition system including, but not limited to, a
microprocessor (microcontroller), programmable logic
device (PLD), memory and an analog to digital
converter (A/D). One preferred embodiment of the
invention uses the microprocessor to periodically
sample the impedance data of the output signal, store
the data onto memory and process the data to determine
variances in the impedance which indicate the presence
of CPR and/or motion artifacts in the ECG signal. In
one preferred embodiment of the present invention, the
programmable logic device controls the interface to
the analog to digital converter (A/D) and stores the
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
18
sampled data into a local memory buffer. The
programmable logic device then interrupts the
microprocessor to sample the impedance data contained
in the buffer via a data bus. The microprocessor may
also be directly interfaced to the analog to digital
converter and use internal timing or interrupts for
the sampling frequency. Additionally, the
microprocessor may be a microcontroller and have the
memory, analog to digital converter and other
peripherals on a single chip.
As is well known in the art, defibrillators
generally comprise the circuitry for generating the
defibrillation pulse including, but not limited to, a
battery pack, a charger circuit, capacitors and an
H-bridge circuit. The defibrillator of the present
invention may also contain an LCD screen, voice
synthesizer and speaker for instructing the rescuer.
The defibrillator data acquisition system of the
present invention samples the thoracic impedance data
on a regular interval, preferably every five
milliseconds. The data acquisition system is
preferably capable of measuring patient impedances
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
19
from 10 ohms to 300 ohms, but could also measure other
impedance ranges. The device stores the data in
random access memory (RAM) for immediate processing,
but may additionally store the data onto a removable
flash card for post-incident analysis. The
defibrillator may also store the data on other types
of memory including internal or external flash memory,
magnetic media optical media, etc.
Additionally, the defibrillator may apply digital
filtering techniques before and/or after storing the
impedance signal data.
As discussed above, the defibrillator also
contains an ECG sensing circuit to determine the
condition of the patient's heart. As is well known in
the art, there are several techniques for sensing
patient ECGs.
The ECG is typically sampled by the defibrillator
data acquisition system in a similar manner to the
technique described hereinabove. The defibrillator
evaluates the patient's rhythm by looking for a
regularly recurring QRS complex found in a normal ECG
sinus rhythm, such as that shown in Fig 2. When the
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
device is not able to detect a normal ECG sinus
rhythm, but instead finds an irregular rhythm, such as
that illustrated in Fig. 3, or a shockable arrhythmia,
such as a high rate ventricular tachycardia, the
device follows a rescue protocol to provide therapy to
the patient.
The defibrillator uses three-seconds of ECG data
to create one data segment. The ECG data segment is
classified in a binary fashion as either shockable or
non-shockable. The ECG data segments are used to
create a binary sequence of shockable or non-shockable
segments. The sequence is then evaluated for the
criterion of a shockable rhythm. This criterion may
be "n-out-of-n" segments or related to a number of
consecutive segments. The defibrillator begins to
charge the capacitors and prepares to deliver therapy
as long as the above criterion continues to be met.
An example scenario of sudden cardiac arrest
(SCA) is shown in Fig. 1. In this example, the
patient initially has a heart pulse. The initial
rhythm may be normal, weak or an arrythmia. The
patient experiences SCA when the heart rhythm
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
21
transitions to VF due to one of many medical reasons.
If the patient receives a shock within the first few
minutes of the onset of VF, there is a strong
likelihood that the VF rhythm will be eliminated and
the patient's normal heartbeat restored. If the
patient does not receive a defibrillation shock or the
shock is unsuccessful, the rhythm eventually
deteriorates toward fine VF over time.
There is a lower probability of resuscitating the
patient when the rhythm reaches fine VF. The
defibrillator of the present invention, however, uses
a threshold to determine if the fine VF rhythm is
still shockable. If the rhythm amplitude is below the
threshold, the defibrillator will not declare a
shockable rhythm. When the rhythm is below the
shockable threshold, CPR and/or intravenous therapy is
more effective for the patient. This therapy may once
again stimulate the heart, so that defibrillation
therapy can be applied.
A heart with no electrical activity is in
asystole, as shown in Fig. 5. Without the flow of
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
22
oxygen to the brain.and other vital organs, the
patient eventually reaches biological death.
When the patient is in fine VF below the
threshold, or in asystole, the defibrillator of the
present invention prompts the rescuer to begin
administering CPR to the patient. During CPR, the
patient's ECG may appear sinusoidal or semi-sinusoidal
in nature.
However, in many cases., the rescuer may be poorly
trained in CPR or in the process of transporting the
patient into an ambulance. In this case, the ECG may
not appear sinusoidal or semi-sinusoidal. More
particularly, the ECG signal (which consists of the
CPR signal superimposed over the fine VF or asystole
ECG) may appear to resemble VF, as is shown in Fig. 3.
In other words, where the patient is in fine VF below
threshold or asystole, which would indicate a non-
shockable condition, the application of non-ideal CPR
or the occurrence of patient motion may alter the
patient's ECG so that it appears similar to a VF
condition, which is a shockable condition. Thus, the
administration of non-ideal CPR or the occurrence of
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
23
patient motion may modify the ECG signal so that a
non-shockable condition appears as a shockable
condition, thereby interfering with proper therapy.
For this reason, it can be a significant advantage if
the device can identify the presence of CPR or motion
artifacts in the ECG signal, which can obscure the
true nature of the heart rhythm and thus cause the
device to misdirect the user to cease administration
of CPR and stand back for a defibrillating shock.
As those skilled in the art can appreciate, a
common problem in prior art AEDs is identifying and
eliminating these CPR and motion artifacts from the
underlying ECG rhythm, which can cause the
defibrillator to misinterpret the rhythm as described
hereinabove.
In view of this problem, the defibrillator of the
present invention uses the patient's transthoracic
impedance signal, independently of the patient's ECG
signal, to determine if the patient's ECG signal is
distorted due to the presence of CPR or motion
artifacts. In other words, the defibrillator analyzes
the patient's transthoracic impedance signal to
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
24
determine if CPR is being administered and/or if the
patient is undergoing motion, in which case CPR and/or
motion artifacts will be present in the patient's ECG
signal, therefore altering the patient's base ECG
signal so as to render it unreliable for diagnosis.
Significantly, the present invention uses the
transthoracic impedance signal independently of the
ECG signal to determine if the ECG signal is distorted
due to the presence of CPR and/or motion artifacts.
The current invention achieves this by measuring
variations in the impedance signal. As shown in Fig.
11, the impedance signal is sampled, the sampled
impedance signal is smoothed using a signal averaging
technique, and the smoothed impedance signal is stored
in the device memory. The signal averaging down-
samples the rate to 100 samples per second. The
defibrillator uses the most current 3-second period to
evaluate the impedance signal. The 3-second period is
further divided into 0.5-second segments. The
0.5-second segments are classified in a binary fashion
as either noisy (containing CPR and/or motion
artifact) or not noisy. The defibrillator of the
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
present invention only considers signal frequencies
greater than approximately 0.66Hz for this
classification. The defibrillator determines if the
0.5-second segment is noisy by comparing impedance
variation from peak-to-trough or trough-to-peak to a
preset threshold. For example, the current invention
uses a 10.5 ohm threshold to determine if the segment
is noisy, but other thresholds may be used as well.
Thus, if the impedance delta exceeds 10.5 ohms, the
segment is classified as noisy. These 0.5 segments
are used to create a binary sequence over the
3-seconds. The sequence is evaluated for a criterion
of CPR and/or motion artifact. This may be
"n-out-of-6" segments or related to a number of
consecutive segments within the 3-second period. If
the 3-second period is declared noisy, then the device
interrupts the ECG analysis for the corresponding ECG
segment and allows the rescuer to continue performing
CPR. The device also notifies the rescuer that the
ECG analysis has been interrupted by displaying a
message on the LCD. In high motion situations, the
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
26
ECG is interrupted until the device can appropriately
assess the patient's rhythm.
In other words, with the defibrillator of the
present invention, the device simultaneously tracks
the patient's ECG signal and changes in transthoracic
impedance. By way of example but not limitation, when
the device detects the appearance of a VF state in the
ECG signal, the device checks to see if this state
accompanied by changes in the thoracic impedance
signal which are indicative of the presence of CPR
and/or patient motion; if so, the device notes that
the measured ECG signal may not be indicative of a
true VF state, and therefore does not recommend
defibrillation shock. On the other hand, if the
appearance of the VF state in the ECG signal is not
accompanied by changes in the transthoracic impedance
signal indicative of CPR and/or patient motion, the
device concludes that the measured ECG signal is
reflective of the true VF state and therefore
recommends defibrillation shock.
It will, of course, be appreciated that, as shown
in Fig. 12, it may be desirable to set different
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
27
impedance thresholds at different modes of the
device's function to optimize operation of the device.
For example, it may be desirable to set a relatively
high impedance threshold during the "analyze rhythm",
"shock advised" and "press to shock" phases of the
device's operation whereby to reduce the likelihood of
determining that there is a CPR and/or patient motion
condition during those phases; correspondingly, it may
be desirable to set a relatively low impedance
threshold during the "check patient" and "CPR pause"
phases of the device's operation whereby to increase
the likelihood of determining that there is a CPR
and/or patient motion condition during those phases.
Additionally, the defibrillator of the present
invention allows the rescuer to continue to perform
CPR without interruption, but dependent on the
operating mode, the device may periodically prompt the
user to stand clear and re-analyze the patient's
rhythm. For example, the defibrillator may allow the
user to perform CPR uninterrupted in "check patient"
mode for a time period of one minute before prompting
to re-analyze the patient's rhythm.
CA 02617232 2008-01-29
WO 2006/015348 PCT/US2005/027347
28
Modifications
It is to be understood that the present invention
is by no means limited to the particular constructions
herein disclosed and/or shown in the drawings, but
also comprises any modifications or equivalents within
the scope of the invention.
